Inflammatix
PrivateLast Round
Series E
Sep 12, 2024
Total Funding Raised
$263M
Company Overview
Inflammatix is a molecular diagnostics company that develops rapid tests to measure immune responses and assist healthcare providers in diagnosing acute infections and sepsis using advanced machine-learning algorithms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inflammatix Comps
Public and private peers based on sector, stage, and business model.
Inflammatix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 12, 2024 | ||||
| Series D | Mar 16, 2021 | ||||
| Series C | Jan 10, 2020 | ||||
| Grant | Nov 14, 2019 |
Key People
Founding team and executive leadership
Inflammatix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Series C, Series E, Series D |
| Grey Sky Venture Partners | Series C |
| Administration for Strategic Preparedness and Response | Grant |
| Khosla Ventures | Series D, Series C, Series E |
| Iberis Capital | Series E |
| OSF Ventures | Series D, Series E |
| Vesalius Biocapital Partners | Series E |
Inflammatix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inflammatix's valuation, stock price, and market status.
